Corrigendum
- PMID: 35213085
- PMCID: PMC8877710
- DOI: 10.1111/bpa.13053
Corrigendum
Erratum for
-
NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.Brain Pathol. 2021 May;31(3):e12957. doi: 10.1111/bpa.12957. Brain Pathol. 2021. PMID: 34043263 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
